Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.
about
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Severe hepatic dysfunction is ...... ts in phase 1 clinical trials.
@ast
Severe hepatic dysfunction is ...... ts in phase 1 clinical trials.
@en
type
label
Severe hepatic dysfunction is ...... ts in phase 1 clinical trials.
@ast
Severe hepatic dysfunction is ...... ts in phase 1 clinical trials.
@en
prefLabel
Severe hepatic dysfunction is ...... ts in phase 1 clinical trials.
@ast
Severe hepatic dysfunction is ...... ts in phase 1 clinical trials.
@en
P2093
P2860
P1433
P1476
Severe hepatic dysfunction is ...... nts in phase 1 clinical trials
@en
P2093
P2860
P304
P356
10.1016/J.THROMRES.2015.10.024
P577
2015-10-20T00:00:00Z